Loading...
Generate Biomedicines (GENB, $14.7) was one of top quarterly gainers, jumping +3 to $14.7 per share. A.I.dvisor analyzed 590 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.